Franklin Resources Inc. raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 2.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,300,240 shares of the company's stock after purchasing an additional 28,480 shares during the period. Franklin Resources Inc. owned about 1.08% of Privia Health Group worth $23,092,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Canada Pension Plan Investment Board acquired a new stake in Privia Health Group in the 2nd quarter valued at $26,000. GAMMA Investing LLC grew its position in shares of Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock valued at $31,000 after purchasing an additional 845 shares during the period. Nisa Investment Advisors LLC increased its stake in shares of Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company's stock worth $31,000 after purchasing an additional 930 shares in the last quarter. Signaturefd LLC increased its stake in shares of Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company's stock worth $34,000 after purchasing an additional 626 shares in the last quarter. Finally, Quarry LP lifted its stake in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company's stock valued at $60,000 after buying an additional 2,533 shares in the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.
PRVA has been the subject of several research reports. Macquarie began coverage on Privia Health Group in a research note on Monday. They set an "outperform" rating and a $25.00 price objective for the company. Barclays upped their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an "equal weight" rating in a report on Friday, November 8th. JPMorgan Chase & Co. boosted their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a research report on Friday, November 29th. Truist Financial upped their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Finally, KeyCorp initiated coverage on shares of Privia Health Group in a research note on Friday, October 11th. They issued an "overweight" rating and a $23.00 target price on the stock. Two investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $24.80.
Read Our Latest Research Report on PRVA
Shares of NASDAQ:PRVA opened at $20.13 on Friday. The company has a market capitalization of $2.42 billion, a price-to-earnings ratio of 201.32, a PEG ratio of 5.45 and a beta of 0.83. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $24.30. The business has a 50-day moving average price of $20.25 and a 200 day moving average price of $19.11.
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.